We tested compensation by other activator E2Fs and found that knocking down E2F1 alongside E2F3, but not E2F2, reduced UHRF1 expression in osteosarcoma (Supplementary Fig. 2C, D). This evidence concerns the gene E2F2 and osteosarcoma.